Cann Group Limited (CAN.AX)

AUD 0.04

(-2.56%)

EBITDA Summary of Cann Group Limited

  • Cann Group Limited's latest annual EBITDA in 2024 was -35.53 Million AUD , down -100.05% from previous year.
  • Cann Group Limited's latest quarterly EBITDA in 2024 FY was N/A , up 34.9% from previous quarter.
  • Cann Group Limited reported an annual EBITDA of -17.76 Million AUD in 2023, down -4.19% from previous year.
  • Cann Group Limited reported an annual EBITDA of -19.79 Million AUD in 2022, down -16.35% from previous year.
  • Cann Group Limited reported a quarterly EBITDA of N/A for 2024 FY, up 34.9% from previous quarter.
  • Cann Group Limited reported a quarterly EBITDA of -5.36 Million AUD for 2024 Q4, down 0.0% from previous quarter.

Annual EBITDA Chart of Cann Group Limited (2024 - 2015)

Historical Annual EBITDA of Cann Group Limited (2024 - 2015)

Year EBITDA EBITDA Growth
2024 -35.53 Million AUD -100.05%
2023 -17.76 Million AUD -4.19%
2022 -19.79 Million AUD -16.35%
2021 -17.29 Million AUD -44.07%
2020 -13.9 Million AUD -33.91%
2019 -9.5 Million AUD -126.83%
2018 -3.87 Million AUD -130.85%
2017 -2.46 Million AUD -47.42%
2016 -1.41 Million AUD -11060.1%
2015 - AUD 0.0%

Peer EBITDA Comparison of Cann Group Limited

Name EBITDA EBITDA Difference
Althea Group Holdings Limited -28.56 Million AUD -24.421%
ECS Botanics Holdings Ltd 3.22 Million AUD 1200.767%
Ecofibre Limited -38.34 Million AUD 7.323%
Elixinol Wellness Limited -6.8 Million AUD -422.128%
Hygrovest Limited -1.1 Million AUD -3121.759%
IDT Australia Limited -5.13 Million AUD -592.305%
Invion Limited -4.57 Million AUD -677.295%
Little Green Pharma Ltd -4.64 Million AUD -665.315%
Live Verdure Ltd -12.51 Million AUD -184.027%
Medical Developments International Limited -29.44 Million AUD -20.682%
Vitura Health Limited 7.07 Million AUD 602.186%
Vita Life Sciences Limited 13.09 Million AUD 371.309%